Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
54.4M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
17.4M
-
Shares change
-
+84.7K
-
Total reported value, excl. options
-
$182M
-
Value change
-
+$142K
-
Number of buys
-
17
-
Number of sells
-
-10
-
Price
-
$10.46
Significant Holders of CLIMB BIO, INC. - Common Stock, par value $0.0001 per share (CLYM) as of Q4 2021
37 filings reported holding CLYM - CLIMB BIO, INC. - Common Stock, par value $0.0001 per share as of Q4 2021.
CLIMB BIO, INC. - Common Stock, par value $0.0001 per share (CLYM) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.4M shares
of 54.4M outstanding shares and own 31.93% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (13.2M shares), SAMLYN CAPITAL, LLC (1.7M shares), Woodline Partners LP (373K shares), BlackRock Inc. (356K shares), VANGUARD GROUP INC (306K shares), Monashee Investment Management LLC (300K shares), JPMORGAN CHASE & CO (208K shares), Tudor Investment Corp Et Al (195K shares), GOLDMAN SACHS GROUP INC (164K shares), and GEODE CAPITAL MANAGEMENT, LLC (116K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.